Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
7.07
-0.07 (-0.98%)
At close: Dec 5, 2025, 4:00 PM EST
7.21
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:50 PM EST
Bicycle Therapeutics Stock Forecast
Stock Price Forecast
According to 11 professional analysts, the 12-month price target for Bicycle Therapeutics stock ranges from a low of $10 to a high of $44. The average analyst price target of $18.73 forecasts a 164.92% increase in the stock price over the next year.
Price Target: $18.73 (+164.92%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Bicycle Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 5 | 6 | 7 | 7 | 5 | 4 |
| Hold | 3 | 3 | 3 | 3 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 12 | 12 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Initiates $10 | Hold | Initiates | $10 | +41.44% | Nov 24, 2025 |
| Citizens | Citizens | Buy Maintains $10 → $12 | Buy | Maintains | $10 → $12 | +69.73% | Oct 31, 2025 |
| RBC Capital | RBC Capital | Buy → Hold Downgrades $27 → $11 | Buy → Hold | Downgrades | $27 → $11 | +55.59% | Oct 31, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $22 → $10 | Buy | Maintains | $22 → $10 | +41.44% | Aug 12, 2025 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $17 → $13 | Hold | Maintains | $17 → $13 | +83.88% | Aug 12, 2025 |
Financial Forecast
Revenue This Year
32.62M
from 35.28M
Decreased by -7.54%
Revenue Next Year
30.88M
from 32.62M
Decreased by -5.32%
EPS This Year
-3.93
from -2.90
EPS Next Year
-3.83
from -3.93
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 41.6M | 63.0M | ||||
| Avg | 32.6M | 30.9M | ||||
| Low | 27.0M | 3.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 18.0% | 93.2% | ||||
| Avg | -7.5% | -5.3% | ||||
| Low | -23.5% | -90.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -3.82 | -2.56 | ||||
| Avg | -3.93 | -3.83 | ||||
| Low | -4.31 | -4.91 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.